Phylodynamics of the emergence of influenza viruses after cross-species transmission

PloS One
Leila Rahnama, Stéphane Aris-Brosou

Abstract

Human populations are constantly exposed to emerging pathogens such as influenza A viruses that result from cross-species transmissions. Generally these sporadic events are evolutionary dead-ends, but occasionally, viruses establish themselves in a new host that offers a novel genomic context to which the virus must adjust to avoid attenuation. However, the dynamics of this process are unknown. Here we present a novel method to characterize the time it takes to G+C composition at third codon positions (GC3 content) of influenza viruses to adjust to that of a new host. We compare the inferred dynamics in two subtypes, H1N1 and H3N2, based on complete genomes of viruses circulating in humans, swine and birds between 1900-2009. Our results suggest that both subtypes have the same fast-adjusting genes, which are not necessarily those with the highest absolute rates of evolution, but those with the most relaxed selective pressures. Our analyses reveal that NA and NS2 genes adjust the fastest to a new host and that selective pressures of H3N2 viruses are relaxed faster than for H1N1. The asymmetric nature of these processes suggests that viruses with the greatest adjustment potential to humans are coming from both birds and swine for...Continue Reading

References

Mar 21, 1997·Science·J K TaubenbergerT G Fanning
Jun 20, 1998·Bioinformatics·J O McInerney
Apr 12, 2002·Systematic Biology·John P HuelsenbeckAmy M Levine
Feb 28, 2003·Virus Research·Gareth M Jenkins, Edward C Holmes
Mar 28, 2003·Nature·Neil M FergusonRobin M Bush
Mar 23, 2004·Nucleic Acids Research·Robert C Edgar
Feb 4, 2005·Molecular Biology and Evolution·Ziheng YangRasmus Nielsen
Feb 11, 2005·Molecular Biology and Evolution·A J DrummondO G Pybus
Mar 5, 2005·Applied and Environmental Microbiology·Patrick D Schloss, Jo Handelsman
Oct 7, 2005·Nature·Jeffery K TaubenbergerThomas G Fanning
Apr 22, 2006·Science·Björn OlsenRon A M Fouchier
Apr 22, 2006·Science·Thijs KuikenBryan T Grenfell
May 11, 2006·PLoS Biology·Alexei J DrummondAndrew Rambaut
May 13, 2006·The Journal of General Virology·Jun-ichi KawadaTsuneo Morishima
Jan 31, 2007·Nature Reviews. Genetics·Martha I Nelson, Edward C Holmes
May 8, 2007·Molecular Biology and Evolution·Ziheng Yang
May 18, 2007·Nature·Nathan D WolfeJared Diamond
May 25, 2007·Molecular Biology and Evolution·Lone SimonsenEdward C Holmes
Sep 13, 2007·PloS One·Stéphane Aris-Brosou
Oct 19, 2007·Journal of Virology·Yiming BaoDavid Lipman
Nov 13, 2007·BMC Evolutionary Biology·Alexei J Drummond, Andrew Rambaut
Apr 18, 2008·Nature·Andrew RambautEdward C Holmes
May 9, 2008·PLoS Computational Biology·Julius B LucksJoshua B Plotkin
Sep 6, 2008·Microbiology and Molecular Biology Reviews : MMBR·Colin R ParrishPeter Daszak
Sep 13, 2008·Annual Review of Microbiology·Nadia NaffakhSylvie van der Werf
Apr 21, 2009·Methods in Molecular Biology·David Posada
Jun 16, 2009·Nature·Gabriele NeumannYoshihiro Kawaoka
Oct 2, 2009·Clinical and Vaccine Immunology : CVI·Stanley A Plotkin
Oct 27, 2009·Journal of Medical Virology·Simona PuzelliUNKNOWN Italian ARI Study Group
Aug 21, 2010·BMC Evolutionary Biology·Emily H M WongLeo L M Poon
Nov 4, 2010·Nucleic Acids Research·Paul FlicekStephen M J Searle
Nov 27, 2010·Molecular Biology and Evolution·Mario dos ReisRichard A Goldstein
Jan 5, 2011·Nucleic Acids Research·Michael Y Galperin, Guy R Cochrane

❮ Previous
Next ❯

Software Mentioned

PAUP
TreeAnnotator
jModelTest
ensembl
Muscle
Pal2Nal
in
GCUA
house Perl script
DOTUR

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.